Home  >  Health Check  >  Milestone in HIV prevention for women
Health Check
Milestone in HIV prevention for women
Health Check
Dec 2, 2020

In the week of World AIDS Day, Health Check looks at what's being described as a milestone in the prevention of HIV infection in women. It is a form of pre-exposure prophylaxis (PrEP) - an injection every 8 weeks of a drug called cabotegravir. A clinical trial has been comparing it to a daily PrEP pill which is already known to be effective at preventing HIV infection. The injection regimen was about 90% more effective at shielding women from the virus than the daily tablet. The trial involves more than 3,000 women in seven Southern and East African countries. Claudia talks to study co-leader Sinead Delany-Moretlwe of the University of Witwatersrand about why this form of PrEP seems to be so effective and whether it will be affordable for low and middle income countries. Chhavi Sachdev reports on informal health workers known as ‘chhota doctors’ who are the backbone of primary health care for the hundreds of millions of rural people in India. They are not formally recognised as health care providers by the authorities and lack medical degrees, but they are the first port of call for many when people feel ill, particularly during India’s coronavirus lockdown. At a time when so many people are stuck indoors working at home, World Health Organisation has published new recommendations on how much physical activity we should be doing for the sake of our health. We talk to Fiona Bull, head of the WHO’s physical activity unit. James Gallagher is the Health Check guest this week talking about Covid-19 vaccines, vitamin D and a step towards a blood test to predict Alzheimer’s disease.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: Female doctor giving a young female patient an injection in her consultation room. Photo credit: Henk Badenhorst/Getty Images.)

More Episodes
Jun 3, 2026
Health at the football World Cup

From heat exhaustion to dengue fever - monitoring public health risks at the biggest tournament in football history.

With millions of fans travelling to the USA, Canada and Mexico for the men’s football World Cup, Claudia Hammond speaks to Professor Rebecca Katz from Georgetown University in Washington DC who is the Director of the newly set up Health Security Operations Center, a surveillance hub to track threats to health, monitoring the risk of diseases such as measles, dengue and chikungunya.

With the World Cup coinciding with rainy season in Mexico, which also means mosquito season, our reporter Rogelio Navarro in Guadalajara brings us the latest on efforts in Jalisco state to prevent outbreaks of dengue which is transmitted by mosquitoes.

And the potential for health issues due to extreme heat has caused concerns amongst players, spectators and scientists. At the men’s FIFA Club World Cup in the USA last year Chelsea and Argentina midfielder Enzo Fernandez spoke out about the difficulties of playing in high temperatures. We hear from Norwegian international midfielder Morten Thorsby and Douglas Casa, CEO of the Korey Stringer Institute and Professor of Kinesiology at the University of Connecticut, who have written to tournament organisers, FIFA, calling for stronger heat protection measures for players and spectators.

Presenter: Claudia Hammond Producer: Jonathan Blackwell

Image: Aziz Behich and Mathew Leckie of Australia drink water during the FIFA World Cup Qatar 2022 Group D match between Australia and Denmark at Al Janoub Stadium on November 30, 2022 in Al Wakrah, Qatar


26min 29sec


May 20, 2026
Ebola outbreak in the Democratic Republic of Congo

An Ebola outbreak that started in the north-east of the Democratic Republic of Congo (DRC) is spreading in the region and has been declared a health emergency. Health Check’s Claudia Hammond has the latest with BBC reporter Emery Makumeno in Kinshasa, Heather Kerr, Country Director for the International Rescue Committee (IRC) in the DRC, and Professor Trudie Lang, head of the Global Health Network at Oxford University.

Claudia is joined in the studio by BBC health reporter Laura Foster. They discuss the call for more testing of drugs with under-represented groups, after a study of Black African Americans, smokers, and people with complex health conditions in the US showed that an asthma drug, Tezepelumab, led to 70% fewer asthma attacks in people with severe asthma.

They also hear about new hearing technology which can read peoples’ brainwaves to help people to pick out the single voice they want to listen to in a noisy room. Claudia speaks to Nima Mesgarani, Associate Professor at the Zuckerman Institute at  Columbia University in New York.

And Claudia and Laura discuss why some cancer patients would fancy a pre-consultation with an AI avatar before a consultation with their real-life doctor? It's the subject of research by Dr Adam Raben, Chair of Radiation Oncology at the Helen F Graham Cancer Center at Christiana Care in Newark, Delaware, USA; presented at the European Society for Radiotherapy and Oncology Congress.

Presenter: Claudia Hammond Producer: Jonathan Blackwell & Clare Salisbury

Image: A Congolese health worker checks the temperature to screen a traveller at the Grande Barrier border following confirmation of an Ebola outbreak involving the Bundibugyo strain, at the border crossing point between Congo and Rwanda, in Goma, Democratic Republic of Congo May 18, 2026


26min 29sec


Milestone in HIV prevention for women

--:--
--:--